World News

North Korea attempted to hack Covid-19 vaccine technology from Pfizer

A nurse takes part in the Covid-19 coronavirus vaccination mock drill at a vaccination center in Seoul – KIM HONG-JI /AFP

North Korea has attempted to steal Covid-19 vaccine technology by hacking Pfizer Inc according to South Korea’s National Intelligence Service (NIS), Yonhap news agency reported on Tuesday.

South Korea’s Yonhap did not report when the alleged hacking took place or whether it was successful.

Last year suspected North Korean hackers tried to break into at least nine health organisations, including Johnson & Johnson, Novavax Inc, and AstraZeneca.

South Korea’s intelligence agency said it had foiled North Korean attempts to hack into South Korean companies developing coronavirus vaccines.

Digital espionage against health bodies, vaccine scientists and drugmakers has intensified during the Covid-19 pandemic as state-backed hacking groups scramble to obtain the latest research and information about the outbreak.

North Korea is often accused of turning to an army of hackers to fill cash-strapped government coffers amid international sanctions that ban most international trade with the country.

Health experts have said the country’s hackers may be more interested in selling the stolen vaccine data than using it to develop a homegrown vaccine.

North Korea is expected to receive nearly two million doses of the AstraZeneca-Oxford Covid-19 vaccine by the first half of this year through the COVAX vaccine-sharing programme.

North Korea has not confirmed any coronavirus infection, but the NIS had said an outbreak there cannot be ruled out as the country had active trade and people-to-people exchanges with China before closing the border in early 2020.

Leader Kim Jong-un’s wife, Ri Sol Ju, who has not been seen in public for more than a year, is keeping a low profile to avoid a risk of infection from Covid-19, NIS said, according to Yonhap.


ALSO READ  Italy denies entry to private plane with Americans on holiday
Tags

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close